Novo lacks rights to novo.com domain

The pharmaceutical giant Novo has not secured the rights to the domain novo.com, according to reports from Finans. This follows the company's recent decision to remove ‘Nordisk’ from its name.

Experts warn that the lack of ownership poses a significant security risk. Because customers and partners may naturally attempt to contact the company using email addresses ending in @novo.com, there is a danger that confidential information could be sent to the wrong recipients.